In the present study, we tried to clarify the potentially protective role of Bcl-x L , an anti-apoptotic member of the Bcl-2 family of proteins, in Parkinson's disease (PD). Using in situ hybridization on human postmortem mesencephalon sections, we show that in PD patients Bcl-x L mRNA expression per dopaminergic neuron was almost double that of controls. We also show that, ultrastructurally, this effect may be mediated by a redistribution of Bcl-x L from the cytosol to the outer mitochondrial membrane. © 2002 Elsevier Science (USA)
Several recent human postmortem studies have suggested that dopaminergic (DA) neurons die by apoptosis in Parkinson's disease (PD), as well as in several in vivo and in vitro models of the disease (Hartmann & Hirsch, 2000) .
Proteins of the Bcl-2 family are important regulators of apoptosis (Desagher and Martinou, 2000) . Their anti-apoptotic members, such as Bcl-2 and Bcl-x L , appear to act primarily at the level of the mitochondrial outer membrane by inhibiting the opening of the mitochondrial permeability transition pores and the subsequent release of cytochrome c from the mitochondrial intermembrane space into the cytosol, resulting in caspase activation (Desagher and Martinou, 2000) . Yet, Bcl-x L has also been shown to inhibit cytochrome c release independently of the mitochondrial permiability transition pore. In line with this, it is possible to observe a migration of Bcl-x L towards the outer mitochondrial membrane during the apoptotic process (Hengartner, 2000).
It would therefore seem possible that Bcl-x L plays a role in PD pathophysiology, given the mitochondrial dysfunction and apoptotic cell death reported in this disease. Specifically, (a) mitochondrial complex I abnormalities are well recognized in idiopathic PD (Leonard & Schapira, 2000) ; (b) these may ultimately result in a disruption of the outer mitochondrial membrane and subsequent release of cytochrome c into the cytosol; (c) Bcl-x L appears to act primarily at the mitochondrial outer membrane, and (d) Bcl-x L is stably expressed in the adult central nervous system. We therefore attempted to clarify the potential role of Bcl-x L in apoptotic cell demise in PD by conducting a study in the human postmortem brain.
MATERIALS AND METHODS

Immunohistochemistry
A qualitative study of Bcl-x L protein expression was conducted on series of free-floating, 40-m-thick mesencephalon sections from two control subjects and two idiopathic PD patients matched for age at death
